Focused gene expression microarray of tumors from 596 men with prostate cancer using RNA from archival FFPE tissue
After therapy for prostate cancer many men develop a rising PSA. Such men may develop a local or metastatic recurrence that warrants further therapy. However many men will have no evidence of disease progression other than the rising PSA and will have a good outcome. A case-control design, incorporating test and validation cohorts, was used to test the association of gene expression results with outcome after PSA recurrence. Since clinical training and validation analysis requires tissue fro...
Provenance — who produced it, who reused it
Linked to 14 papers in the literature. Roles are inferred factual signals (who deposited the data vs who reused it), with counts — never a judgement about any author.
- MYBL2 disrupts the Hippo-YAP pathway and confers castration resi... 2021 · 136 cites
- Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes t... 2016 · 125 cites
- NF-κB Gene Signature Predicts Prostate Cancer Progression 2014 · 116 cites
- Androgen deprivation–induced NCoA2 promotes metastatic and castr... 2014 · 99 cites
- YAP1 overexpression contributes to the development of enzalutami... 2021 · 85 cites
9 further papers cite this accession but reuse could not be confirmed.
Deep data QC
metadata only · no data-level QC for this typeStandardized, field-standard QC computed by touching the data — every metric states how it was obtained
measured = computed from the data · extrapolated/reported = derived or from the repository · dq-1.0 · provisional — verify independently